World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
104
Citations
35334
World Ranking
622
National Ranking
58

Medicine

D-Index
105
Citations
35847
World Ranking
6827
National Ranking
658

B. Paul Morgan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where B. Paul Morgan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 557 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

B. Paul Morgan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where B. Paul Morgan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 104 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

B. Paul Morgan is affiliated with Cardiff University in the United Kingdom. Their research primarily focuses on medicine, with significant contributions spanning neurology, immunology, cardiology and cardiovascular medicine, physiology, and molecular biology. Their work addresses multiple complex biomedical topics with a particular emphasis on disease mechanisms and treatment development.

The scientist's main research topics include:

  • Complement system in diseases
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Alzheimer's disease research and treatments
  • Cardiomyopathy and Myosin Studies
  • COVID-19 Clinical Research Studies
  • Barrier Structure and Function Studies
  • SARS-CoV-2 and COVID-19 Research

Recent notable publications by B. Paul Morgan include:

  • "Research priorities for the COVID-19 pandemic and beyond: A call to action for psychological science," 2020, British Journal of Psychology
  • "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy," 2021, Journal of Medicinal Chemistry
  • "Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease," 2022, Brain
  • "Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report," 2020, Nature Communications
  • "Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration," 2020, Nature Communications

The frequent co-authors collaborating with Morgan include:

  • Wioleta M. Zelek (49 publications together)
  • Fady I. Malik (17 publications together)
  • Darren T. Hwee (16 publications together)
  • Nikoleta Daskoulidou (13 publications together)
  • Sarah M. Carpanini (12 publications together)

Their work is often published in scientific venues such as:

  • Immunobiology (17 publications)
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature (7 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (6 publications)
  • Journal of Medicinal Chemistry (5 publications)
  • Brain Behavior and Immunity (5 publications)

This profile reflects a professional engaged deeply in multidisciplinary biomedical research, with a substantial focus on immune system mechanisms, neurodegenerative diseases, cardiovascular medicine, and infectious diseases including COVID-19. Their publication record suggests active collaboration and contribution to the evolving landscape of medical science.

Best Publications

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • C3 glomerulopathy: consensus report

    Matthew C. Pickering;Vivette D. D'agati;Carla M. Nester;Richard J. Smith

  • Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.

    S Meri;B P Morgan;A Davies;R H Daniels

  • Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts

    Mark S Cragg;Suzanne M Morgan;H T Claude Chan;B Paul Morgan

  • Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.

    Elena Goicoechea de Jorge;Claire L. Harris;Jorge Esparza-Gordillo;Luis Carreras

  • Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects

    B P Morgan

  • Immunopathology of secondary‐progressive multiple sclerosis

    John W. Prineas;Eunice E. Kwon;Eun‐Sook Cho;Leroy R. Sharer

  • Complement, a target for therapy in inflammatory and degenerative diseases.

    B. Paul Morgan;Claire L. Harris;Claire L. Harris

  • The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation.

    Kathy Triantafilou;Timothy R. Hughes;Martha Triantafilou;B. Paul Morgan

  • Complement deficiency and disease.

    B.Paul Morgan;Mark J Walport

  • Complement components of the innate immune system in health and disease in the CNS.

    Philippe Gasque;Y. D. Dean;Eamon Patrick McGreal;J. VanBeek

  • Soluble Forms of Toll-Like Receptor (TLR)2 Capable of Modulating TLR2 Signaling Are Present in Human Plasma and Breast Milk

    Emmanuel LeBouder;Julia E. Rey-Nores;Neil K. Rushmere;Martin Grigorov

  • Extrahepatic complement biosynthesis: where, when and why?

    B. P. Morgan;P. Gasque

  • Increased Complement Biosynthesis By Microglia and Complement Activation on Neurons in Huntington's Disease☆

    S.K Singhrao;J.W Neal;B.P Morgan;P Gasque

  • The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement.

    S J Piddlesden;H Lassmann;F Zimprich;B P Morgan

  • Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.

    Aled Clayton;Claire L. Harris;Jacquelyn Court;Malcolm D. Mason

  • Dimerization of complement factor H-related proteins modulates complement activation in vivo

    E. Goicoechea de Jorge;J. J. E. Caesar;T. H. Malik;M. Patel

  • Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system.

    P. Gasque;S. K. Singhrao;J. W. Neal;O. Götze

  • Complement Regulatory Proteins

    B. Paul Morgan;Andrew L. Harris

  • Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis.

    S J Piddlesden;M K Storch;M Hibbs;A M Freeman

Frequent Co-Authors

Claire L. Harris
Claire L. Harris Newcastle University
Santiago Rodríguez de Córdoba
Santiago Rodríguez de Córdoba Spanish National Research Council
Awen Gallimore
Awen Gallimore Cardiff University
Susan M. Lea
Susan M. Lea University of Oxford
Seiichi Matsuo
Seiichi Matsuo Nagoya University
Margarita López-Trascasa
Margarita López-Trascasa Autonomous University of Madrid
V. Michael Holers
V. Michael Holers University of Colorado Denver
Pieter Jelle Visser
Pieter Jelle Visser Amsterdam University Medical Centers
Oscar Llorca
Oscar Llorca Spanish National Research Council
Anthony K. Campbell
Anthony K. Campbell Cardiff University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare roles often require advanced nursing degrees and specializations. Many professionals start with foundational programs like online ABSN programs for non nurses, which allow individuals from diverse backgrounds to enter nursing quickly and efficiently.

From there, accelerated options such as the accelerated FNP program provide a streamlined pathway to become a Family Nurse Practitioner (FNP), a role with broad applicability in clinical and research settings related to immunology.

Many nurses choose to specialize further. For example, transitioning from an FNP to an acute care nurse practitioner enhances clinical expertise and opens up higher-paying opportunities. Guidance on this pathway can be found in resources like fnp to acute care np transition articles.

Salary prospects are an important consideration. Understanding the dnp salary by specialty can help students and practitioners make informed career decisions based on location and expertise.

Best Scientists Citing B. Paul Morgan

Trending Scientists

Recently Published Articles